Suchergebnisse - "Daw, Stephen"

PubPharm (51)

1

Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma : prevalence and possible implications for initial staging

enthalten in: Pediatric radiology | 2024

von Stoevesandt, D. | Ludwig, C. | Mauz-Körholz, C. | +21

2

Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging

enthalten in: Pediatric radiology | 2024

von Stoevesandt, D. | Ludwig, C. | Mauz-Körholz, C. | +21

3

Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults

enthalten in: Blood | 2023

von Harker-Murray, P. | Mauz-Körholz, C. | Leblanc, T. | +16

CommentIn: Blood. 2023 Apr 27;141(17):2037-2038. - PMID 37103949

4

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1) : a titration study

enthalten in: The Lancet. Oncology | 2023

von Mauz-Körholz, C. | Landman-Parker, J. | Fernández-Teijeiro, A. | +31

CommentIn: Lancet Oncol. 2023 Mar;24(3):196-197. - PMID 36858717

5

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1) : a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial

enthalten in: The Lancet. Oncology | 2022

von Mauz-Körholz, C. | Landman-Parker, J. | Balwierz, W. | +32

CommentIn: Lancet Oncol. 2022 Jan;23(1):11-13. - PMID 34895480

6

18F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma : A Prospective Study with 18F-FDG PET/CT as the Reference Standard

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2021

von Verhagen, M. | Menezes, L. | Neriman, D. | +6

7

Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging : Results from the EuroNet-PHL-C1 trial

enthalten in: Pediatric blood & cancer | 2021

von Kurch, L. | Mauz-Körholz, C. | Fosså, A. | +31

CommentIn: Pediatr Blood Cancer. 2022 Jul;69(7):e29560. - PMID 34971071

8

The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma : a retrospective single-centre series

enthalten in: British journal of haematology | 2021

von McMillan, A. | O'Neill, A. | Townsend, W. | +11

9

The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma : a retrospective single‐centre series

enthalten in: British Journal of Haematology | 2021

von McMillan, A. | O'Neill, A. | Townsend, W. | +11

10

Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients—Importance of multimodality imaging : Results from the EuroNet‐PHL‐C1 trial

enthalten in: Pediatric Blood & Cancer | 2021

von Kurch, L. | Mauz‐Körholz, C. | Fosså, A. | +31

1
2
3
4
5
6
Nächster »
[6]